Ironwood Pharmaceuticals, Inc.
IRWD
$0.7267
-$0.0233-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 880.00K | -2.46M | 9.21M | -1.05B | -1.00B |
| Total Depreciation and Amortization | 2.01M | 2.04M | 1.64M | 1.80M | 1.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.92M | 98.79M | 104.20M | 1.16B | 1.17B |
| Change in Net Operating Assets | 739.00K | 25.81M | 31.69M | 35.25M | 11.28M |
| Cash from Operations | 103.55M | 124.17M | 146.74M | 148.24M | 183.43M |
| Capital Expenditure | -142.00K | -353.00K | -386.00K | -328.00K | -273.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -3.98M | -26.55M | -1.03B | -1.03B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -142.00K | -4.33M | -26.94M | -1.03B | -1.03B |
| Total Debt Issued | 150.00M | 150.00M | 150.00M | 400.00M | 400.00M |
| Total Debt Repaid | -265.00M | -275.00M | -325.00M | -125.00M | -100.00M |
| Issuance of Common Stock | 11.01M | 11.81M | 11.82M | 12.44M | 6.36M |
| Repurchase of Common Stock | -737.00K | -737.00K | -737.00K | -616.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.25M | -29.06M | -26.90M | -29.20M | -29.20M |
| Cash from Financing | -106.97M | -142.99M | -190.82M | 257.62M | 277.16M |
| Foreign Exchange rate Adjustments | -32.00K | -103.00K | -80.00K | -29.00K | -53.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.60M | -23.25M | -71.10M | -620.54M | -565.78M |